Log in
Enquire now
Genemod

Genemod

Genemod is a lab management software founded in 2018 by Jacob Lee.

OverviewStructured DataIssuesContributors

Contents

genemod.net
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Software
Software
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
Enterprise software
Enterprise software
Software as a service (SaaS)
Software as a service (SaaS)
...
Location
Seattle
Seattle
Founder
‌
Jin Choe
0
Jacob Lee
Jacob Lee
0
AngelList URL
angel.co/genemod
Legal Name
Genemod
Number of Employees (Ranges)
11 – 50
Full Address
Seattle, Washington 98109, US
Place of Incorporation
Delaware
Delaware
Investors
Defy Ventures
Defy Ventures
Omicron Media
Omicron Media
Underdog Labs
Underdog Labs
‌
Canaan Partners Scout Fund
‌
Omicron
Canaan
Canaan
Defy Partners
Defy Partners
Unpopular Ventures
Unpopular Ventures
Founded Date
2018
Total Funding Amount (USD)
3,200,000
Latest Funding Round Date
October 2020
Latest Funding Type
Seed
Seed
Wellfound ID
genemod
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
1,700,000
Public/Private
Private
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Genemod

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.